Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Trajan Group Holdings Ltd ( (AU:TRJ) ).
Trajan Group Holdings Limited announced it will release its Full Year Results for the Financial Year ending June 30, 2025, on August 28, 2025. A live webcast and Q&A session will be hosted by the company’s CEO and CFO, allowing investors to engage and submit questions. This announcement is part of Trajan’s ongoing efforts to maintain transparency and engage with its stakeholders, potentially impacting its market positioning and investor relations.
The most recent analyst rating on (AU:TRJ) stock is a Buy with a A$1.20 price target. To see the full list of analyst forecasts on Trajan Group Holdings Ltd stock, see the AU:TRJ Stock Forecast page.
More about Trajan Group Holdings Ltd
Trajan Group Holdings Limited is a global developer and manufacturer of analytical and life sciences products and devices. The company focuses on enabling science that benefits personal health through scientific tools and solutions, used in analyzing biological, food, and environmental samples. Trajan supports the shift towards decentralized, personalized, data-based healthcare, with a workforce of over 600 people and manufacturing sites in the US, Australia, Europe, and Malaysia.
Average Trading Volume: 40,258
Technical Sentiment Signal: Sell
Current Market Cap: A$137.1M
For a thorough assessment of TRJ stock, go to TipRanks’ Stock Analysis page.